The 61st ASH Annual Meeting: Unwrapping the Best From Hematology's Christmas
2019 ASH News Daily Editor Dr. Ayesha Zia recaps the 61st ASH Annual Meeting and Exposition which took place early December in Orlando.
Act Fast! Making a Difference After Traumatic Brain Injury With Tranexamic Acid
Dr. Tseng discusses several studies that investigate the efficacy and safety of tranexamic acid in patients with traumatic brain injury.
Our Contributing Editors provide coverage of the most influential breakthroughs of 2019 for the field of hematology.
2019 ASH News Daily Editor Dr. Ayesha Zia recaps the 61st ASH Annual Meeting and Exposition, which took place early December in Orlando.
Drs. Gaurav Goyal and Ronald Go discuss the diagnosis and management of Erdheim-Chester disease, a MAPK-ERK pathway-driven histiocytic neoplasm.
January/February 2020Volume 17, Issue 1
View all Features articles
View all Diffusion articles
In her inaugural President's Column, 2020 ASH President Dr. Stephanie Lee previews the year ahead at ASH and reviews some of the breakthroughs of the past decade.
View all president's column articles
View all Ask the Hematologist articles
View all Clinical Trials Corner articles
View all Mini Review articles
ASH continues to advocate for adequate coverage and reimbursement for chimeric antigen receptor T-cell (CAR-T) therapy. In early August, the Centers for Medicare and Medicaid Services (CMS) finalized policies impacting both reimbursement of and coverage for CAR-T therapy. The final Inpatient Prospective Payment System (IPPS) rule, published on August 2, and the final Decision Memo for CAR T-cell Therapy for Cancers, issued August 7.
ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2018.
ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2018.
In 2018, ASH worked to ensure patient access to care through a number of methods including ensuring drug access, pain management-related issues, and the Affordable Care Act.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology